Literature DB >> 10987820

Tau promoter confers neuronal specificity and binds Sp1 and AP-2.

A Heicklen-Klein1, I Ginzburg.   

Abstract

Tau, a microtubule-associated protein, is encoded by a single gene, whose expression is primarily neuronal. In this work, we defined an 80-bp region of the tau promoter that confers tau protein with neuronal expression. This fragment works in conjunction with an endogenous initiation region to activate neuronal precursor-specific transcription of the tau promoter and works independently of this initiation region to confer nerve growth factor inducibility. Furthermore, this 80-bp fragment binds both Sp1 and AP-2 proteins. DNase I foot-print analysis revealed a third protein binding region at the center of this 80-bp fragment in neuronal cells. Mutation within any of these three protein binding sites decreases transcriptional activation of the tau gene. Comprehension of the interactions that occur between cis- and trans-regulatory elements of the tau promoter is important to understand the regulation of tau expression during normal development and changes that may occur in many cases of dementia, including Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987820     DOI: 10.1046/j.1471-4159.2000.0751408.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

1.  Alzheimer's amyloid-β oligomers rescue cellular prion protein induced tau reduction via the Fyn pathway.

Authors:  Rong-Jie Chen; Wei-Wei Chang; Yu-Chun Lin; Pei-Lin Cheng; Yun-Ru Chen
Journal:  ACS Chem Neurosci       Date:  2013-07-18       Impact factor: 4.418

2.  Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8.

Authors:  Iwona Sachrajda; Marcin Ratajewski
Journal:  Mol Genet Genomics       Date:  2010-11-03       Impact factor: 3.291

3.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  Association between Polymorphisms of the AKT1 Gene Promoter and Risk of the Alzheimer's Disease in a Chinese Han Population with Type 2 Diabetes.

Authors:  Sheng-Yuan Liu; He-Dan Zhao; Jin-Long Wang; Tong Huang; Hua-Wei Tian; Li-Fen Yao; Hua Tao; Zhong-Wei Chen; Chang-Yi Wang; Si-Tong Sheng; Hua Li; Bin Zhao; Ke-Shen Li
Journal:  CNS Neurosci Ther       Date:  2015-07-14       Impact factor: 5.243

5.  Secondary RNA structure and nucleotide specificity contribute to internal initiation mediated by the human tau 5' leader.

Authors:  Bethany L Veo; Leslie A Krushel
Journal:  RNA Biol       Date:  2012-09-20       Impact factor: 4.652

6.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors:  Lina Adwan; Gehad M Subaiea; Riyaz Basha; Nasser H Zawia
Journal:  J Neurochem       Date:  2014-10-18       Impact factor: 5.372

Review 7.  miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Ravi Kumar Gutti; Nigel H Greig; Ian A Tamargo
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Authors:  Lina Adwan; Gehad M Subaiea; Nasser H Zawia
Journal:  Neuropharmacology       Date:  2014-01-21       Impact factor: 5.250

Review 9.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

10.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

Authors:  D K Lahiri; B Maloney; N H Zawia
Journal:  Mol Psychiatry       Date:  2009-11       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.